Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Amicus Therapeutics to Present at the 42nd Annual J.P. Morgan Healthcare Conference
-
GRIID Infrastructure Inc. Receives Commencement of Delisting Notice From the NYSE
-
Invivyd Submits Request for Emergency Use Authorization (EUA) to U.S. FDA for VYD222 for the Pre-exposure Prevention of COVID-19 in Immunocompromised Adults and Adolescents
-
Esperion and Daiichi Sankyo Europe Announce $125 Million Amendment to Their Collaboration, Including Resolution of Pending Litigation
-
Braemont Capital Announces Firm Promotions and Industry Award Honors
-
Lexeo Therapeutics to Present at the 42nd Annual J.P. Morgan Healthcare Conference
-
Alta Equipment Group Announces Preferred Stock Dividend
-
Veganuary’s Expert Panel Determines: Purple Sweet Potato is the 2024 Vegetable of the Year
-
iTeos to Present at the 42nd Annual J.P. Morgan Healthcare Conference
-
SEALSQ To Launch SEALCOIN, a digital token and advanced cryptocurrency protocol, at the Davos Space IoT and Cybersecurity Event on January 17, 2024
-
Matinas BioPharma to Present at Biotech Showcase 2024
-
Editas Medicine to Present at the 42nd Annual J.P. Morgan Healthcare Conference
-
Entrada Therapeutics Promotes Nathan J. Dowden to President
-
IGM Biosciences to Present at the 42nd Annual J.P. Morgan Healthcare Conference
-
Hepsiburada’s New CFO M. Seçkin Köseoğlu Takes Office Effective January 1, 2024
-
Sanner Group strengthens medical device design and development capabilities with the acquisition of Springboard Pro
-
Immunocore to present at the 42nd Annual J.P. Morgan Healthcare Conference
-
Columbus confirms acquisition of Endless Gain
-
Asensus Surgical, Inc. to Present at the 42nd Annual J.P. Morgan Healthcare Conference
-
Net Asset Value(s)
-
Form 8.3 - LXi REIT plc
-
Form 8.3 - LondonMetric Property plc
-
Form 8.3 - Smart Metering Systems plc
-
DSM: Net Asset Value(s)
-
Affimed Announces Sale of Wholly-Owned Subsidiary AbCheck
-
Agios Announces Phase 3 ENERGIZE Study of Mitapivat Met Primary Endpoint and Both Key Secondary Endpoints in Adults with Non-Transfusion-Dependent Alpha- or Beta-Thalassemia
-
Dyne Therapeutics Announces Positive Initial Clinical Data from ACHIEVE Trial in DM1 Patients and DELIVER Trial in DMD Patients Demonstrating Promise of the FORCE™ Platform in Developing Therapeutic
-
Ampersand Biomedicines Acquires AbCheck to Accelerate Platform and Product Development
-
NIO Inc. Announces Repurchase Right Notification for 0.00% Convertible Senior Notes due 2026
-
Radware Schedules Conference Call for Its Fourth Quarter and Full Year 2023 Earnings
-
Lancaster Resources Announces Spin-Off Agreement with Subsidiary and Record Date
-
Ragnarok X : Next Genration Received a ISBN Code by Chinese Government
-
GWSO INC Announces Acquisition of AQST USA LLC, Paving the Way for a Clean Energy Revolution
-
Enovis Completes Acquisition of LimaCorporate S.p.A
-
U.S. Energy™ and Strataflex Midstream Complete Their First Jet Fuel Delivery to Harry Reid International Airport
-
Notice of the Annual General Meeting of RTX on 25 January 2024
-
Director/PDMR Shareholding
-
GSI Technology Receives Award from U.S. Air Force Research Laboratory to Demonstrate High-Data Computation Use Cases Leveraging Its Next-Generation APU
-
Copenhagen Infrastructure Partners acquires early-stage Danish solar PV portfolio from Soltec
-
Flash News: OKX Wallet Launches Vaultka Bonus Event Offering Users Up to 11% Bonus Rewards
-
CRYPTOBLOX PROVIDES YEAR END SUMMARY AND CORPORATE UPDATE
-
Fraser Institute News Release: Higher provincial university spending generally does not result in more educated populations
-
OBI Pharma Announces U.S. FDA Clearance of IND Application for a Phase 1/2 Study of OBI-992
-
Notification of major shareholding - correction
-
Flash News: OKX NFT Marketplace Adds Support for Aptos Inscriptions and Integrates with BlueMove Marketplace
-
HqO Further Propels Global Commercial Real Estate Transformation with Launch of ‘Best Spaces to Work in London’
-
No. 1 2024 Hugo Dorph resigns his position as CCO
-
Alvotech Clinical Study Results Demonstrate Therapeutic Equivalence between Biosimilar Candidate AVT06 and Reference Product Eylea® (aflibercept)
-
Serstech receives order of 5.5 MSEK from US partner Safeware
-
Form 8.5 (EPT/RI) - musicMagpie Plc
